Clinical Trial Update: Posoleucel (ALVR105) for the Treatment of Adenovirus Infection in Pediatric and Adult Participants Receiving Standard of Care Following Allogeneic Hematopoietic Cell Transplantation [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating posoleucel (ALVR105) for treating adenovirus infection after allogeneic hematopoietic cell transplantation was terminated; results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenovirus Infection

Drugs mentioned

• Posoleucel (Posoleucel)

Snippet

Sponsor: AlloVir | Conditions: Adenovirus Infection | Phase 3 | Status: TERMINATED | Results posted: 2024-05-08